IN kidney transplantations between identical twins, when the recipient originally suffered from chronic glomerulonephritis, a major cause of late transplant failure has proved to be the development of ...

Fibrocor Therapeutics strengthens its clinical strategy with the appointment of four world-leading nephrology and genetics experts to its Clinical Advisory Board (CAB), reinforcing its scientific ...

Kidney replacement therapy for primary glomerular disease was 16.6 per million population. Highest therapy rates were linked to immunoglobulin A nephropathy and focal segmental glomerulosclerosis.

The transmission electron microscopy (TEM)-based artificial intelligence tool is the first clinically applicable AI system for the diagnosis and quantitative analysis of glomerular diseases. The ...

Air pollutants were associated with adverse glomerular disease outcomes although most exposures were below the US Environmental Protection Agency’s recommended safe levels. Greater exposure to fine ...

Sobi® (STO: SOBI) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending the marketing ...

The FDA approved the C3 and C3b inhibitor in July for C3 glomerulopathy and immune-complex ...

Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or ...

At University of Utah Health, we care for all types of kidney conditions, including hypertension. Our kidney treatment services include plasma therapy—also known as plasmapheresis. We also treat hard ...